Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015) (original) (raw)
Ahmed, S.F., Achermann, J.C., Arlt, W. et al. (14 more authors) (2016)Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015). Clinical Endocrinology, 84 (5). pp. 771-788. ISSN 0300-0664
Abstract
It is paramount that any child or adolescent with a suspected disorder of sex development (DSD) is assessed by an experienced clinician with adequate knowledge about the range of conditions associated with DSD. If there is any doubt, the case should be discussed with the regional DSD team. In most cases, particularly in the case of the newborn, the paediatric endocrinologist within the regional team acts commonly as the first point of contact. This clinician should be part of a multidisciplinary team experienced in management of DSD and should ensure that the affected person and parents have access to specialist psychological support and that their information needs are comprehensively addressed. The underlying pathophysiology of DSD and the strengths and weaknesses of the tests that can be performed should be discussed with the parents and affected young person and tests undertaken in a timely fashion. Finally, in the field of rare conditions, it is imperative that the clinician shares the experience with others through national and international clinical and research collaboration.
Metadata
| Authors/Creators: | Ahmed, S.F.Achermann, J.C.Arlt, W.Balen, A.Conway, G.Edwards, Z.Elford, S.Hughes, I.A.Izatt, L.Krone, N.  https://orcid.org/0000-0002-3402-4727Miles, H.O'Toole, S.Perry, L.Sanders, C.Simmonds, M.Watt, A.Willis, D. |
|---|---|
| Copyright, Publisher and Additional Information: | © 2015 The Authors. Clinical Endocrinology published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| Dates: | Accepted: 11 July 2015Published (online): 13 August 2015Published: 13 May 2016 |
| Institution: | The University of Sheffield |
| Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield) |
| Depositing User: | Symplectic Sheffield |
| Date Deposited: | 22 Nov 2016 10:02 |
| Last Modified: | 22 Nov 2016 10:02 |
| Published Version: | http://dx.doi.org/10.1111/cen.12857 |
| Status: | Published |
| Publisher: | Wiley |
| Refereed: | Yes |
| Identification Number: | https://doi.org/10.1111/cen.12857 |